Amedisys, Inc. (NASDAQ:AMED – Free Report) – Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for Amedisys in a note issued to investors on Wednesday, January 29th.

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. Whit Mayo has given his Hold ...

BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...

UnitedHealth Group and Amedisys have asked the courts to dismiss the federal government's challenge to their $3.3 billion merger, arguing that the Department of Justice (DOJ) has not made a clear ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...

The deal, disclosed in June, was meant to offload assets as UnitedHealth and Amedisys explored a merger.

Amedisys has quashed a deal to sell more than 100 home health centers to a Dallas-based company. The Baton Rouge-based company announced the termination of the deal with VitalCaring late Wednesday.

Health insurer UnitedHealth and home health company Amedisys were, at that time, in talks for a $3.3 billion merger. In November, the Justice Department filed an antitrust lawsuit to block the merger.

UnitedHealth Group and Amedisys have terminated their deal to sell medical centers to VitalCaring Group, scuttling a transaction aimed at easing antitrust concerns over a tie-up in the home health ...

A Birmingham landfill again causing issues for neighbors in Trussville. Homeowners say the smell is getting worse even in the ...